Clinical Trials Browser

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04121975 2019-10-10

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Phase 2 Unknown

82 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04096911 2019-09-20

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Phase 2 Unknown

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03550755 2019-08-30

V3-Cervix

Phase 2 Unknown

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03972722 2019-06-05

CC

Phase 2 Unknown

89 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03912402 2019-05-09

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Phase 2 Unknown

49 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02349958 2019-04-16

HIPEC/IPHC

Phase 2 Unknown

200 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms

NCT03622827 2018-08-14

ChESS

Phase 2 Unknown

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03469531 2018-08-13

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Phase 2 Unknown

100 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Neoplasms

NCT03546855 2018-06-06

Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.

Phase 2 Unknown

69 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02432365 2017-10-30

Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy

Phase 2 Unknown

64 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02835404 2016-07-18

Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

Phase 2 Unknown

200 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02705612 2016-03-10

Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer

Phase 2 Unknown

60 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02039791 2015-08-19

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer

Phase 2 Unknown

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

MITO CERV 2

Evaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer

GCR-05

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy

Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Donafenib for Recurrent Cervical Cancer

Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

H101 Combined With Camrelizumab for Recurrent Cervical Cancer

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

A Study of Carilizumab Combined With Concurrent Chemoradiotherapy

AK105 Combined With Anlotinib in Patients With Cervical Cancer

Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer

PORCH

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

CRTCP

A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors

CQGOG0101

Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy

A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

V3-Cervix

CC

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

HIPEC/IPHC

ChESS

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.

Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy

Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer